Drug search by name
Moxetumomab pasudotox-tdfk Intravenous and Prohance
Determining the interaction of Moxetumomab pasudotox-tdfk Intravenous and Prohance and the possibility of their joint administration.
Check result:
Moxetumomab pasudotox-tdfk Intravenous <> Prohance
Relevance: 18.07.2022
Reviewer: Shkutko P.M., M.D., in
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Moxetumomab pasudotox-tdfk Intravenous
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
The list of popular interactions
- Moxetumomab pasudotox-tdfk Intravenous-ProHance Injection
- Moxetumomab pasudotox-tdfk Intravenous-Prohist LQ
- Moxetumomab pasudotox-tdfk Intravenous-Prolensa
- Moxetumomab pasudotox-tdfk Intravenous-Prolensa ophthalmic
- Moxetumomab pasudotox-tdfk Intravenous-Proleukin
- Moxetumomab pasudotox-tdfk Intravenous-Prolex D
- Prohance-Moxifloxacin
- Prohance-Moxifloxacin (Systemic)
- Prohance-Moxifloxacin Hydrochloride
- Prohance-Moxifloxacin Injection
- Prohance-Moxifloxacin Intravenous
- Prohance-Moxifloxacin Tablets
Doktika World
Interaction with food and lifestyle
Disease interaction